Zhang Zhenrong, Feng Hongxiang, Zhao Heng, Hu Jian, Liu Lunxu, Liu Yang, Li Xiaofei, Xu Lin, Li Yin, Lu Xike, Fu Xiangning, Yang Haiying, Liu Deruo
Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing 100029, China.
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai 200030, China.
J Thorac Dis. 2019 May;11(5):1838-1848. doi: 10.21037/jtd.2019.05.20.
Sublobar resection has emerged as an alternative to lobectomy for management of early-stage non-small cell lung cancer (NSCLC). However, controversy remains as to whether it is adequate for elderly patients. The present study aimed to comparatively study the perioperative outcomes and overall survival of sublobar resection lobectomy for management of elderly patients (≥65 years) with clinical stage I NSCLC.
This is a multicenter retrospective cohort study. Clinical stage I NSCLC patients who underwent lobar or sublobar resection (segmentectomy and wedge resection) at the Department of Thoracic Surgery of 10 tertiary hospitals between January 2014 and September 2017 were retrospectively reviewed from the national collaborative prospective lung cancer database (LinkDoc Technology Co, Ltd., Beijing, China). Clinical data on demographic and tumor characteristics, surgical details were collected. Perioperative outcomes and overall survival were analyzed by using propensity score matching to adjust for selection bias. Subgroup analysis was further carried out to explore the potential sources of heterogeneity.
Among the 1,579 eligible patients, 1,164 (73.7%) underwent lobectomy and 415 (26.3%) underwent sublobar resection (106 segmentectomy and 309 wedge resection). Sublobar resection was more frequently performed in patients who were elder, had more comorbidities and smaller, left-sided adenocarcinoma (P<0.001). Propensity-matched analysis showed significant association of sublobar resection with less blood loss, shorter operation time, chest drainage and hospital stay, while with less lymph node removal when compared with lobectomy (P<0.001). Short term survival analysis showed comparable results even after adjusted in the matched analysis. Similar results were obtained when limiting patients to those aged >75 years, at pathologic stage I, and those who smoking or undergoing video-assisted thoracoscopic surgery (VATS) or segmentectomy and lobectomy.
Sublobar resection was associated with significantly better perioperative outcomes without compromising short term survival in elderly patients with clinical stage I NSCLC. However, the importance of patient selection and management process, as well as accurate lymph node staging must be acknowledged when making the surgical decision (clinical registration number: NCT03429673).
肺叶下切除已成为早期非小细胞肺癌(NSCLC)治疗中肺叶切除的替代方案。然而,对于老年患者而言,该方法是否足够仍存在争议。本研究旨在比较肺叶下切除与肺叶切除治疗临床I期NSCLC老年患者(≥65岁)的围手术期结局和总生存期。
这是一项多中心回顾性队列研究。从国家协作前瞻性肺癌数据库(北京联科数技有限公司)中回顾性分析2014年1月至2017年9月期间在10家三级医院胸外科接受肺叶或肺叶下切除(肺段切除和楔形切除)的临床I期NSCLC患者。收集了人口统计学和肿瘤特征、手术细节等临床数据。采用倾向评分匹配分析围手术期结局和总生存期,以校正选择偏倚。进一步进行亚组分析以探索异质性的潜在来源。
在1579例符合条件的患者中,1164例(73.7%)接受了肺叶切除,415例(26.3%)接受了肺叶下切除(106例肺段切除和309例楔形切除)。肺叶下切除在年龄较大、合并症较多、肿瘤较小的左侧腺癌患者中更常施行(P<0.001)。倾向评分匹配分析显示,与肺叶切除相比,肺叶下切除与失血量更少、手术时间更短、胸腔引流和住院时间更短相关,但淋巴结清扫较少(P<0.001)。短期生存分析显示,即使在匹配分析中进行校正后结果仍具有可比性。将患者限制为年龄>75岁、病理I期、吸烟或接受电视辅助胸腔镜手术(VATS)或肺段切除和肺叶切除的患者时,也得到了类似结果。
肺叶下切除与临床I期NSCLC老年患者显著更好的围手术期结局相关,且不影响短期生存。然而,在做出手术决策时,必须认识到患者选择和管理过程以及准确的淋巴结分期的重要性(临床注册号:NCT03429673)。